Alex Lukianov

Alex is Chairman and CEO of Tissue Differentiation Intelligence (TDi). He is a serial entrepreneur and immediate past Chairman and CEO of NuVasive, Inc. (de facto founder). He has over 35 years of medical technology industry experience, serving as a senior executive at Medtronic Sofamor Danek, BackCare Group, Smith and Nephew Orthopedics, and a Meadox/Stryker joint venture. He is a long-standing orthopedic industry expert and has received multiple achievement awards in entrepreneurship and leadership, as well as many public appearances at conferences, panels, TV, media, and in Washington, DC.

Alex served on a variety of public, private, and not-for-profit boards including California Health Institute, BIOCOM, Medical Device & Manufacturers Association, Volcano, etc. Currently, he is serving on the public company board of Orthofix, several private and not for profit boards including Chairman and CEO (co-founder) of TDi, Systems Oncology, OnPoint, Holy Trinity Seminary, Chairman of St Photios Orthodox Theological Seminary, and Chairman and CEO of Patriarch Tikhon Russian-American Music Institute.

Alex directs his focus largely on developing new businesses, investments, and the proliferation of the arts. He studied at Rutgers, The State University of New Jersey.